EDWARDS LIFESCIENCES KONECT RESILIA AORTIC VALVED CONDUIT AVC; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11060A |
Device Problems
Device Stenosis (4066); Central Regurgitation (4068)
|
Patient Problems
Chest Pain (1776); Dizziness (2194); Insufficient Information (4580)
|
Event Date 12/01/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was reported that a patient with a 27mm 11060a aortic valve underwent a valve-in-valve procedure after an implant duration of 9 months and 11 days due to stenosis and regurgitation.The procedure was performed with a 23mm 9755rsl transcatheter valve.
|
|
Manufacturer Narrative
|
Manufacturer narrative: updated sections; b5, b7, g3, g6, h6 health effect - clinical code, device code(s), and type of investigation.H11 corrected data: d1, d2, d4 model number and serial number, d6a, and g4 pma/510(k) number.
|
|
Event Description
|
It was reported that a patient with a 23mm magna aortic valve underwent a valve-in-valve procedure after and implant duration of 9 years and 8 months due to severe symptomatic stenosis.The patient presented with chest tightness and dizziness.The tavr procedure was successfully performed with a 23mm 9755rsl valve.The patient was in recovery post-procedure and discharged on pod #4.
|
|
Manufacturer Narrative
|
Updated sections: b7, g3, g6, h6 investigation findings, and investigation conclusions.The device history record (dhr) was unable to be performed, as the device lot/serial number was not provided.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explants and encompasses multiple failure modes, including calcification, non-calcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, nonstructural dysfunction (nsvd) may also play a role in the development of valvular stenosis.Through further investigation, it was determined that the root cause of this event was most likely due to patient related factors.
|
|
Search Alerts/Recalls
|
|
|